Cassava Sciences | PTIE - Ebit

Precio De Mercado
2.03
Cambio Diario
-0.01 -0.49%
Mensual
-0.98%
Anual
-27.76%
Q1 Expectativa
2.21




Ebit Cambio Fecha
Abbott USD 2.54B 358M 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.86M 33.53M 2025-09
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Geron USD -10.79M 3.1M 2025-12
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Novavax USD -134.02M 49.55M 2024-09
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12